Medicines and Poisons (Medicines) Regulation 2021
sec.158Selling S4 restricted medicine
Start here
Get a plain-English read of sec.158
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons (Medicines) Regulation 2021.
sec.158 Selling S4 restricted medicine
This section applies in relation to an S4 medicine that is a restricted medicine for a patient. A pharmacist must not sell the medicine unless the pharmacist reasonably believes— the medicine has been previously prescribed to the patient; and continuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine. A pharmacist must not sell an amount of the medicine that is— if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or otherwise—more than 3 days’ supply of the medicine. s 158 sub 2025 SL No. 60 s 11 (sec.158-ssec.1) This section applies in relation to an S4 medicine that is a restricted medicine for a patient. (sec.158-ssec.2) A pharmacist must not sell the medicine unless the pharmacist reasonably believes— the medicine has been previously prescribed to the patient; and continuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine. (sec.158-ssec.3) A pharmacist must not sell an amount of the medicine that is— if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or otherwise—more than 3 days’ supply of the medicine.
- (a) the medicine has been previously prescribed to the patient; and
- (b) continuing the patient’s treatment with the medicine is urgent and essential for the patient’s wellbeing; and
- (c) it is not practicable for the patient to obtain a prescription for the medicine before needing to continue treatment with the medicine.
- (a) if the medicine is pre-packed—more than the smallest available size of a manufacturer’s pack of the medicine; or
- (b) otherwise—more than 3 days’ supply of the medicine.